A carregar...
Harnessing gemcitabine metabolism: a step towards personalized medicine for pancreatic cancer
Pancreatic cancer is a lethal malignancy with a 5-year survival rate of only 6%. Surgical resection remains the only cure, yet even after resection the 5-year survival is only 20% due to a high recurrence rate. Thus, a high proportion of patients with this disease will ultimately require systemic ch...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3481558/ https://ncbi.nlm.nih.gov/pubmed/23118809 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758834012453755 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|